Search Results - "Stepensky, P."

Refine Results
  1. 1
  2. 2

    Early lymphocyte collection for anti‐CD19 CART production improves T‐cell fitness in patients with relapsed/refractory diffuse large B‐cell lymphoma by Dubnikov Sharon, T., Assayag, M., Avni, B., Kfir‐Erenfeld, S., Lebel, E., Gatt, M. E., Goldschmidt, N., Stepensky, P., Asherie, N., Grisariu, S.

    Published in British journal of haematology (01-07-2023)
    “…Summary Background Chimeric antigen receptor (CAR) T cells targeted to the CD19 B‐cell antigen form an approved treatment for patients with relapsed/refractory…”
    Get full text
    Journal Article
  3. 3

    Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen by Tsirigotis, P D, Resnick, I B, Avni, B, Grisariu, S, Stepensky, P, Or, R, Shapira, M Y

    Published in Bone marrow transplantation (Basingstoke) (01-11-2014)
    “…The incidence and outcome of moderate-to-severe veno-occlusive (VOD) disease was analyzed in 271 consecutive patients with hematological malignancies who…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The use of whole exome sequencing for the diagnosis of autosomal recessive malignant infantile osteopetrosis by Shamriz, O., Shaag, A., Yaacov, B., NaserEddin, A., Weintraub, M., Elpeleg, O., Stepensky, P.

    Published in Clinical genetics (01-07-2017)
    “…Autosomal recessive malignant infantile osteopetrosis is a congenital disease characterized by pathologically increased bone density. Recently, the use of…”
    Get full text
    Journal Article
  6. 6

    Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations by Shadur, B., Abuzaitoun, O., NaserEddin, A., Even-Or, E., Zaidman, I., Stepensky, P.

    Published in Clinical immunology (Orlando, Fla.) (01-01-2019)
    “…The incorporation of next generation sequencing into routine immunological practice has enabled the identification of novel inborn errors of disease, helped…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience by Averbuch, D., Avaky, C., Harit, M., Stepensky, P., Fried, I., Ben-Ami, T., Temper, V., Peled, Y., Troen, H., Masarwa, R., Abu Ahmad, W., Weintraub, M., Revel-Vilk, S., Engelhard, D.

    Published in Infection (01-06-2017)
    “…Purpose Data on non-fermentative Gram-negative rods (NFGNR) bacteremia in children with malignancies are limited. The aim of this study was to present clinical…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients by Averbuch, D., Horwitz, E., Strahilevitz, J., Stepensky, P., Goldschmidt, N., Gatt, M. E., Shapira, M. Y., Resnick, I. B., Engelhard, D.

    Published in Infection (01-10-2013)
    “…Purpose Colistin is increasingly used as the last-resort treatment option against infections caused by multidrug-resistant (MDR) Gram-negative pathogens, but…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20